Natural Alternatives International Appoints Vice President of CarnoSyn® Brands to Support Existing Business Opportunities and Spearhead Market Expansion InitiativeSeptember 18, 2018 CARLSBAD, CA
CARLSBAD, Calif., Sept. 18, 2018 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq :NAII ) is pleased to announce and welcome Nicole Burbank as Vice President of CarnoSyn® Brands. Nicole will be responsible for the leadership of the CarnoSyn® business teams and the advancement of new and existing business opportunities, including the expansion of SR CarnoSyn® beta-alanine into the general wellness and healthy aging categories.
The past 15 years of Nicole's career was spent in various roles in the nutraceutical and natural products industries, including Natrol, Renew Life/Clorox, Pauling Labs, Alacer Corporation/Pfizer and Nestle Waters.
Speaking of her appointment, Nicole said, "I'm honored to become a member of the CarnoSyn team. While we enjoy a strong position within the sports nutrition industry, I see a great deal of opportunity to expand our unique SR CarnoSyn line into the health and wellness and healthy aging categories. I am excited to be a part of the future of the CarnoSyn Brands."
"Nicole's extensive natural product experience and focus on brand development will be a great asset to our business expansion goals," notes Ken Wolf, NAI's President. "Nicole will provide leadership and strategic direction as we continue to grow CarnoSyn brands into new markets and continue our focus on delivering to our customers the highest level of customer service."
About CarnoSyn® Brands:
CarnoSyn® Brands feature two clinically studied, patented ingredients available exclusively from Natural Alternatives International, Inc.: CarnoSyn® instant release beta-alanine and SR CarnoSyn® sustained release beta-alanine. In the sports nutrition segment, both ingredients are well known to deliver benefits for athletic performance: increased strength, enhanced endurance, faster recovery, and greater mental focus.
SR CarnoSyn® is an advanced delivery form of CarnoSyn®, which delivers higher dosing levels of beta-alanine, and is proven to provide benefits for both brain health and muscle function and capacity. In 2017, SR CarnoSyn® was determined to be safe through independent scientific procedures, thus satisfying the technical element of the Generally Recognized as Safe (GRAS) determination. The GRAS affirmation allows NAI to broaden their product offerings beyond the sports nutrition space and focus on the food and beverage industries including medical and other fortified food products. NAI is aggressively pursuing partnerships with key players in the general wellness and healthy aging markets to provide unique SR CarnoSyn® product offerings to the specialty food category.
CarnoSyn® and SR CarnoSyn® are ultra-pure amino acids and banned substance free, backed by NAI's commitment to the highest quality, potency, and manufacturing standards. For more information about CarnoSyn® and SR CarnoSyn®, please visit www.carnosyn.com.
NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI's comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please visit www.nai-online.com.
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our future revenue profits and financial condition, our ability to maintain our patents, generate revenues from the commercialization of our patents and trademarks, secure compliance with our intellectual property rights, and develop, maintain or increase sales to new and existing customers, as well as future economic conditions and the impact of such conditions on our business. We wish to caution readers that these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI's financial performance and the forward-looking statements contained herein are further qualified by other risks, including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K.
Renee Michaelson, CarnoSyn® Marketing Manager, Natural Alternatives International, Inc., at 760-736-7700 or firstname.lastname@example.org.
Website: http://www.carnosyn.com and http://www.nai-online.com